Cargando…

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

Detalles Bibliográficos
Autores principales:	Ji, Dong, Qin, Enqiang, Xu, Jing, Zhang, Dawei, Cheng, Gregory, Wang, Yudong, Lau, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141624/ https://www.ncbi.nlm.nih.gov/pubmed/32278005 http://dx.doi.org/10.1016/j.jhep.2020.03.044

Ejemplares similares

Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19
por: Ji, Dong, et al.
Publicado: (2021)

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

Effect of COVID-19 on patients with compensated chronic liver diseases
por: Ji, Dong, et al.
Publicado: (2020)

Reply to: ‘Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis’
por: Ji, Dong, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study
por: Ji, Dong, et al.
Publicado: (2021)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease
por: Liu, Dong, et al.
Publicado: (2022)

Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease
por: Shao, Qi, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
por: Yu, Cheng-Wei, et al.
Publicado: (2023)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Association between non‐alcoholic fatty liver disease with the susceptibility and outcome of COVID‐19: A retrospective study
por: Wang, Guyi, et al.
Publicado: (2021)

Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update
por: Miranda, Cesare, et al.
Publicado: (2023)

Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
por: Heda, Rajiv, et al.
Publicado: (2021)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Lower serum PRL is associated with the development of non-alcoholic fatty liver disease: a retrospective cohort study
por: Xu, Ping, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Role of Hepatokines in Non-alcoholic Fatty Liver Disease
por: Ke, Yini, et al.
Publicado: (2019)

Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population
por: Li, Min-ran, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19.
por: Bramante, Carolyn T., et al.
Publicado: (2020)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Impact of non-alcoholic fatty liver disease and smoking on colorectal polyps
por: Chen, Qin-Fen, et al.
Publicado: (2017)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
por: Malnick, Stephen D. H., et al.
Publicado: (2022)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Treatment of non-alcoholic fatty liver disease
por: Tolman, Keith G, et al.
Publicado: (2007)

Pathogenesis of non-alcoholic fatty liver disease
por: Dowman, J. K., et al.
Publicado: (2010)

Autophagy and Non-Alcoholic Fatty Liver Disease
por: Lavallard, Vanessa J., et al.
Publicado: (2014)

Non-Alcoholic Fatty Liver Disease in Children
por: SINGER, CRISTINA, et al.
Publicado: (2014)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Delvin, Edgard, et al.
Publicado: (2015)

Iron and non-alcoholic fatty liver disease
por: Britton, Laurence J, et al.
Publicado: (2016)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Apoptosis and non-alcoholic fatty liver diseases
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Bush, Haley, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease and diabetes
por: Hazlehurst, Jonathan M., et al.
Publicado: (2016)

Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4apah5r5iqqepghjjf0c60af0j